SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (21431)6/10/2005 1:35:54 PM
From: hoyasaxa  Respond to of 78748
 
Pharma/Biotech Service Companies- Used to follow them a lot more as well. Those with strong geno/pheno-typing services can be good plays at the right price. Always keeping an eye on LabCorp, Covance and Quest Diagnostics. The key question I think remains: with the drug industry in the shape its in, will big pharma more likely pull more in house or outsource more.....Good luck.

finance.yahoo.com



To: Spekulatius who wrote (21431)11/4/2005 10:26:45 AM
From: Paul Senior  Respond to of 78748
 
PDII with poor earnings. Company selling for less than 2xcash. There's no ltd, according to Yahoo.

Still, as discussed, the business model may not be so solid.

I've lost confidence/patience. I'm closing my exploratory position, and I'll put the stock on my watch list.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News